Heather Flint

Videos

Elevate Exclusive Preview: Hiding in Plain Sight

05/16/2022

This year, Psych Congress Elevate is working to shine a spotlight on the mental health of America’s youth with a preview of the documentary, “Hiding in Plain Sight: Youth Mental Illness.”

This year, Psych Congress...

05/16/2022

Psychiatry & Behavioral Health

News

Six-Month LAI for Treatment of Schizophrenia in Adults Approved by FDA

09/28/2021

Heather Flint ;

The US FDA has approved Janssen Pharmaceutical’s INVEGA HAFYERA (6-month paliperidone palmitate), a long-acting, atypical antipsychotic for adults with schizophrenia.

The US FDA has approved Janssen...

09/28/2021

Psych Congress Network

News

NDA Submission for Major Depressive Disorder and Postpartum Depression Treatments

10/20/2021

Heather Flint ;

New drug application to be submitted to the FDA for a novel therapeutic for the treatment of both major depressive disorder and postpartum depression.

New drug application to be...

10/20/2021

Psych Congress Network

Conference Coverage

APA Bipolar Disorder Preview: What to Expect

05/17/2022

Heather Flint ;

A preview for the APA annual meeting: what to expect for bipolar disorder session.

A preview for the APA annual...

05/17/2022

Psych Congress Network

News

Leading Their Patients on the Psychedelic Therapy Journey: Considerations for Clinicians

09/18/2021

Heather Flint ;

There are several “important considerations for the clinician” in preparing to help lead their client on the journey of psychedelic therapies, said Julie Megler, PHH-NP, at today’s SANA Symposium.

There are several “important...

09/18/2021

Psych Congress Network

News

Lynn-Marie Morski and Rosalind Watts, Most Influential Women in Psychedelics

02/22/2022

Heather Flint ;

Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.

Sana Symposium Steering...

02/22/2022

Psych Congress Network

News

FDA Approves Donepezil Transdermal Patch for Alzheimer Disease

03/21/2022

Heather Flint ;

The US Food and Drug Administration has approved Adlarity® (donepezil transdermal system) for release in the fall of 2022. Adlarity is indicated in the treatment of adults with Alzeheimer-type mild to severe dementia symptoms. Adlarity is...

The US Food and Drug...

03/21/2022

Psych Congress Network

News

The Impact of Pandemic-related Lockdown on Children With ADHD

09/17/2021

Heather Flint ;

According to a recent study, the effects of the COVID-19 pandemic-related lockdown significantly impacted most of the global population, specifically children and adolescents with ADHD.

According to a recent study, the...

09/17/2021

Psych Congress Network

News

Valbenazine Use for Tardive Dyskinesia in Older Adults Proves Efficacious

12/08/2021

Heather Flint ;

Valbenazine use for tardive dyskinesia (TD) in adults aged 65 and older has been deemed efficacious with comparable outcomes to younger adults, according to a post hoc analysis.

Valbenazine use for tardive...

12/08/2021

Psych Congress Network

Perspectives

Suicide Awareness: Rates and Statistics

09/07/2021

Heather Flint ;

September is National Suicide Awareness Month, and September 5 to September 11 is National Suicide Prevention Week. Suicide crosses all age groups, races, ethnicities, and class lines, proving that mental health struggles can impact anyone.

September is National Suicide...

09/07/2021

Psych Congress Network